Efficacy and Safety of Apatinib for Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
Clinical trial NCT03274011 · COMPLETED
Trial details
- NCT number
- NCT03274011
- Sponsor
- Fudan University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-01
- Primary completion
- 2019-03-15
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.